Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06629077

Brain Blood Vessel Responses to Changes in Blood Flow

Cerebrovascular Responses to Acute Hypoperfusion

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
36 (estimated)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
55 Years – 69 Years
Healthy volunteers
Accepted

Summary

Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.

Detailed description

Global cerebral blood flow (CBF) decreases with advancing age; however, some adults have accelerated declines in CBF, placing them at a greater risk of cognitive impairment. However, there is a lack of human studies that investigate the cause or consequence of altered blood flow regulation in the brain. This study will systematically address this gap in knowledge by examining cerebrovascular control in adults during acute physiological challenges (simulated postural change test and breathing increased carbon dioxide) that stimulate a change in CBF.

Conditions

Interventions

TypeNameDescription
DEVICEMRIParticipants will undergo an MRI scan while performing breathing and a simulated postural change task.
DRUGPrazosinA dose of prazosin will be administered based on body weight.
DRUGPlaceboOral placebo

Timeline

Start date
2026-02-26
Primary completion
2027-01-01
Completion
2027-01-01
First posted
2024-10-08
Last updated
2026-03-02

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06629077. Inclusion in this directory is not an endorsement.